Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Ocrelizumab and Cladribine had similar EDSS stability and safety profile in patients with highly active multiple sclerosis

              Author:Alshawaf, Fatemah   Ahmed, Samar   Al-Hashel, Jasem   Alroughani, Raed   

              Session Name:P8: MS Therapeutics 2  

              Topic:MS and Inflammatory Disease  

              Program Number:P8.011  

              Author Institution:Kuwait Institute for Medical Specializations (KIMS), Kuwait, Kuwait  Ministry of health, Al-Minia, Egypt  Ministry of health, Sulibekhat, Kuwait  Ministry of health, Kuwait, Kuwait  

              Real-Life Experience with Erenumab Therapy in the Episodic and Chronic Migraine.

              Author:Alshawaf, Fatemah   Ahmed, Samar   Alroughani, Raed   Al-Hashel, Jasem   

              Session Name:P12: Headache: Clinical Trials and Real World Studies 2  

              Topic:Headache  

              Program Number:P12.004  

              Author Institution:Kuwait Institute for Medical Specializations (KIMS), Kuwait, Kuwait  Ministry of health, Al-Minia, Egypt  Ministry of health, Kuwait, Kuwait  Ministry of health, Sulibekhat, Kuwait